To further evaluate the safety of dihydrocapsiate (4-hydroxy-3-methoxybenzyl 8-methylnonanoate, CAS No. 205687-03-2), a 26—week gavage toxicity study was conducted in Sprague-Dawley rats (20/sex/group). Test animals received either dihydrocapsiate, 100, 300, or 1000 mg/kg/day, or vehicle (medium-chain triglyceride) by gavage and were observed for antemortem and postmortem signs of toxicity including changes in clinical signs, body weights, food consumption, water intake, ophthalmology, clinical pathology (clinical chemistry, hematology, urinalysis), tissue findings (macroscopic and microscopic examination), as well as organ weights. After the end of the dosing period, reversibility was assessed (10/sex/group for the control and 1000 mg/kg groups) following a 4-week recovery period. There were no adverse or toxicological changes observed in clinical signs, body weight, food consumption, water intake, ophthalmology, urinalysis, hematology, blood chemistry, organ weights, or histopathology. It was concluded that the no observable adverse effect level (NOAEL) of dihydrocapsiate was 1000 mg/kg/day for both sexes in this 26—week gavage study.
Yazawa S., Yoneda H., Hosokawa M., et al. Novel capsaicinoid like substances in the fruits of new non-pungent cultivar CH-19 sweet of pepper (Capsicum annuum). Capsicum and Eggplant Newsletter. 2004;23:17-20.
2.
Kobata K., Todo T., Yazawa S., et al. Novel capsaicinoid-like substances, capsiate and dihydrocapsiate, from the fruits of a nonpungent cultivar, CH-19 sweet, of pepper (Capsicum annuum L.). J Agric Food Chem. 1998;46:1696-1697.
3.
Kobata K., Sutoh K., Todo T., et al. Nordihydrocapsiate, a new capsinoids from the fruits of nonpungent pepper, Capsicum annuum. J Nat Prod. 1999;62:335-336.
4.
Kobata K., Kawaguchi M., Watanabe T.Enzymatic synthesis of a capsinoid by the acylation of vanillyl alcohol with fatty acid derivatives catalyzed by lipases. Biosci Biotechnol Biochem. 2002;66:319-327.
5.
Monsereenusorn Y.Subchronic toxicity studies of capsaicin and capsicum in rats. Res Commun Chem Pathol Pharmacol. 1983; 41:95-110.
6.
Akagi A., Sano N., Uehara H., et al. Non-carcinogenicity of capsaicinoids in B6C3F1 mice. Food Chem Toxicol. 1998;36: 1065-1067.
7.
Watanabe E., Kodama T., Masuyama T., Tsubuku S., Otabe A., Mochizuki M., Nakajima M., et al. Studies of the toxicological potential of capsinoids I: Single dose toxicity study and genotoxicity studies of CH-19 Sweet extract. Int J Toxicol. 2008;27(Suppl 3):1-9.
8.
Kodama T., Watanabe E., Masuyama T., Tsubuku S., Otabe A., Mochizuki M., et al. Studies of the toxicological potential of capsinoids: II. A 26-week daily gavage dosing toxicity study of CH-19 Sweet extract in rats . Int J Toxicol. 2008; 27(Suppl 3):11-27.
9.
Kodama T., Watanabe E., Masuyama T., Tsubuku S., Otabe A., Katsumata Y., et al. Studies of the toxicological potential of capsinoids III: A two-generation reproduction study of CH-19 Sweet extract in rats. Int J Toxicol. 2008;27(Suppl 3):29-39.
10.
Bernard BK, Watanabe E., Kodama T., Tsubuku S., Otabe A., Katsumata Y., et al. Studies of the toxicological potential of capsinoids IV: Teratology studies of CH-19 sweet extract in rats and rabbits. Int J Toxicol. 2008;27(Suppl 3):41-57.
11.
Bernard BK, Tsubuku S., Kayahara T., et al. Studies of the toxicological potential of capsinoids X: Safety assessment and pharmacokinetics of capsinoids in healthy male volunteers after a single oral ingestion of CH-19 sweet extract. Int J Toxicol . 2008; 27(Suppl 3):137-147.
12.
Bernard BK, Watanabe E., Kodama T., Tsubuku S., Otabe A., Nakajima M., et al. Studies of the toxicological potential of capsinoids V: Genotoxicity studies of dihydrocapsiate. Intl J Toxicol. 2008;27(S3):59-72.
13.
Watanabe E. , Kodama T., Masuyama T., Tsubuku S., Nakajima M., et al. Studies of the toxicological potential of capsinoids VI: Single dose toxicity study and micronucleus test of commercial grade dihydrocapsiate . Int J Toxicol. 2008 ;27(Suppl 3):73-77.
14.
Kodama T., Watanabe E., Tsubuku S., et al. Studies of the toxicological potential of capsinoids: VII. A 13-week toxicity study of dihydrocapsiate in rats. Int J Toxicol . 2008;27(Suppl 3):79-99.
15.
Watanabe E. , Kodama T., Masuyama T., Tsubuku S., Otabe A., Mochizuki M., Bernard BKStudies of the toxicological potential of capsinoids VIII: A 13-week toxicity study of commercial grade dihydrocapsiate in rats. Intl J Toxicol. 2008;27(Suppl 3): 101-118.
16.
Bernard BK, Watanabe E., Kodama T., Tsubuku S., Otabe A., Ikeya M., et al. Studies of the toxicological potential of capsinoids IX: Teratology studies of dihydrocapsiate in rats and rabbits. Intl J Toxicol . 2008d;27(S3):119-136.
17.
Sokal RR, Rohlf FJBartlett’s test of homogeneity of variances. In: Biometry . San Francisco, CA: W. H. Freeman and Co. 1969: 370-371.
18.
Dunnett CWNew tables for multiple comparisons with a control. Biometrics . 1964;20:482-491.
19.
Steel RGD.A multiple comparison rank sum test: Treatments versus control. Biometrics. 1959;15:560-572.
20.
Fisher R.On the interpretation of w2 from contingency tables, and the calculation of P. J Royal Stat Soc. 1922;85:87-94.
21.
Krinke G., Naylor DC, Schmid S., et al. The incidence of naturally occurring primary brain tumors in the laboratory rat. J Comp Pathol. 1985;95:175-192.
22.
Maekawa A., Onodera H., Takigawa H., et al. Spontaneous tumors of the nervous system and associated organs and/or tissues in rats. Gann. 1984;75:784-791.
23.
Hard G., Johnson K., Cohen S.A comparison of rat chronic progressive nephropathy (CPN) with human renal disease: implications for human risk assessment. Crit Rev Toxicol. 2009;39:332-346.
24.
Bernard BK, Ubukata K., Mihara R., et al. Studies of the toxicological potential of capsinoids: XI. Pharmacokinetic and tissue distribution study of 14C-dihydrocapsiate (a capsinoid) and metabolites in rats. Int J Toxicol. 2010;29(suppl 1):3S-14S.
25.
Shirai Y., Ueno S., Nakayama A., et al. Studies of the toxicological potential of capsinoids XII: A pharmacokinetic study of capsinoid-containing CH-19 sweet extract in rats . Int J Toxicol. 2010; 29(suppl 1):15S-21S.
26.
Takanohashi T., Isaka M., Ubukata K., et al. Studies of the toxicological potential of capsinoids XIII: Inhibitory effects of capsiaicin and capsinoids on cytochrome P450 3A4 in human liver microsomes. Int J Toxicol. 2010;29(suppl 1):22S-26S.
